Dr. Eiju Negoro is a Senior Assistant Professor at the Department of Hematology and Oncology at the University of Fukui Hospital. In 1992 he graduated with an M.D. from the Faculty of Medicine, Fukui Medical University, and from 2002-2011 carried out his Ph.D. and postgraduate work in Medical Science at the Faculty of Medicine at the University of Fukui. In addition to his current role, he has worked as a Junior Resident in the First Department of Internal Medicine, University of Fukui, a Senior Resident in the Department of Internal Medicine at Fukui Red Cross Hospital, a Physician of Hematology at Kurashiki Central Hospital, a physician in the Department of Hematology and Oncology in the Faculty of Medical Sciences, University of Fukui, the Head Physician in the Department of Hematology and Oncology, Fukui Prefectural Hospital, and a Postdoctoral Fellow at the Cleveland Clinic for Translational Hematology & Oncology. Dr. Negoro directs efforts to study the prognostic factor in lymphoma patients. He also focuses on the mutational disease evolution pattern of hypoplastic myelodysplastic syndrome and aplastic anemia. He has won several awards for his work, including awards from the Japanese Society of Internal Medicine (1998), the Japanese Society of Hematology (2004), the Japanese Society of Medical Oncology (2005), the KYO prize for Leukemia Research from the Japan Leukemia Research Fund (2005), and the American Society of Hematology Abstract Achievement Award.
Dr. Eiju Negoro is a Senior Assistant Professor at the Department of Hematology and Oncology at the University of Fukui Hospital. In 1992 he graduated with an M.D. from the Faculty of Medicine, Fukui Medical University, and from 2002-2011 carried out his Ph.D. and postgraduate work in Medical Science at the Faculty of Medicine at the University of Fukui. In addition to his current role, he has worked as a Junior Resident in the First Department of Internal Medicine, University of Fukui, a Senior Resident in the Department of Internal Medicine at Fukui Red Cross Hospital, a Physician of Hematology at Kurashiki Central Hospital, a physician in the Department of Hematology and Oncology in the Faculty of Medical Sciences, University of Fukui, the Head Physician in the Department of Hematology and Oncology, Fukui Prefectural Hospital, and a Postdoctoral Fellow at the Cleveland Clinic for Translational Hematology & Oncology. Dr. Negoro directs efforts to study the prognostic factor in lymphoma patients. He also focuses on the mutational disease evolution pattern of hypoplastic myelodysplastic syndrome and aplastic anemia. He has won several awards for his work, including awards from the Japanese Society of Internal Medicine (1998), the Japanese Society of Hematology (2004), the Japanese Society of Medical Oncology (2005), the KYO prize for Leukemia Research from the Japan Leukemia Research Fund (2005), and the American Society of Hematology Abstract Achievement Award.